Sandra Shpilberg
Fundador en SANY HEAL .
Origen de la red de primer grado Sandra Shpilberg.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Biotechnology | 48 | |
| Private Company | Financial Conglomerates | 4 | |
Nora Therapeutics, Inc.
 Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA.
1
| Extinct | Pharmaceuticals: Major | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Sandra Shpilberg a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer Sales & Marketing Treasurer Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Founder Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin | |
| RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Director of Finance/CFO Founder Founder Chairman | |
| INTERMUNE INC | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Chief Executive Officer Human Resources Officer Corporate Officer/Principal | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
| Yale University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| National Pku Alliance | Director/Board Member Director/Board Member | ||
| ACER THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman Founder | |
| HUMANIGEN, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
Everylife Foundation for Rare Diseases
 Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Miscellaneous Commercial Services | Founder Chief Operating Officer | |
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Raven Biotechnologies, Inc.
 Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Glyko, Inc.
 Glyko, Inc. Medical SpecialtiesHealth Technology Part of BioMarin Pharmaceutical, Inc., Glyko, Inc. discovers, develops, and commercializes carbohydrate enzyme therapeutics. The company is based in Novato, CA. Glyko was acquired by BioMarin Pharmaceutical, Inc. on October 08, 1998 for $14.50 million. | Medical Specialties | Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
| MONOPAR THERAPEUTICS INC. | Biotechnology | Director of Finance/CFO Founder | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| The Reed Institute | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree | |
| SPRUCE BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chairman | |
| THIOGENESIS THERAPEUTICS, CORP. | Financial Conglomerates | Director/Board Member Chairman | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Ocean Biomedical, Inc. (United States)
 Ocean Biomedical, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria, Jonathan Kurtis and Jack A. Elias on January 2, 20219 and is headquartered in Providence, RI. | Miscellaneous Commercial Services | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Graduate Degree Undergraduate Degree | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of Michigan | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Boston College | College/University | Graduate Degree Undergraduate Degree | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| The University of Southampton | College/University | Undergraduate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Masters Business Admin | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Hallin Marine Subsea International Plc
 Hallin Marine Subsea International Plc Oilfield Services/EquipmentIndustrial Services Hallin Marine Subsea International Plc engages in providind subsea services and engineering solutions to the energy industries. The company is headquartered in Douglas, the United Kingdom. | Oilfield Services/Equipment | Corporate Officer/Principal |
Estadísticas
Internacional
| Estados Unidos | 48 |
| Canadá | 2 |
| Reino Unido | 2 |
| Singapur | 2 |
Sectorial
| Health Technology | 30 |
| Consumer Services | 15 |
| Commercial Services | 4 |
| Finance | 3 |
| Industrial Services | 2 |
Operativa
| Director/Board Member | 230 |
| Corporate Officer/Principal | 102 |
| Independent Dir/Board Member | 85 |
| Chief Tech/Sci/R&D Officer | 53 |
| Chief Executive Officer | 51 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Alan J. Lewis | 33 |
| Michael Grey | 32 |
| William Young | 32 |
| Leonard Post | 25 |
| Dan Spiegelman | 24 |
| Joseph Klein | 24 |
| Jean-Jacques Bienaimé | 21 |
| V. Lawlis | 21 |
| Erich Sager | 21 |
| Stephen Aselage | 20 |
| Ken Bate | 19 |
| Randy Meier | 18 |
| Louis C. Drapeau | 13 |
| Bill Aliski | 12 |
| Barbara Nelsen | 11 |
- Bolsa de valores
- Insiders
- Sandra Shpilberg
- Conexiones Empresas
